Company intelligence / Profile preview

Laboratorios Sophia

Zapopan, JALISCO, Mexicosophia.com.mx ↗
Ownership
Private
Development stage
Commercial
01

Overview

The company has several approved ophthalmic products, with some in Phase 1 clinical trials. Their first product approval was in Japan in 1999, followed by Mexico in 2007

Therapeutic areas
OphthalmologyCardiovascularInfectious Diseases
Modalities
Small molecule drugsMonoclonal antibodies
Industry
Biotech
02

Drug pipeline

16 assets

PRO-179

Approved

15 more assets in the full pipeline.

Beyond the preview

Go deeper on Laboratorios Sophia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laboratorios Sophia.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call